CHINA PHARMA HOLDINGS, INC. (CPHI) Total liabilities 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) total liabilities at each fiscal year-end, per SEC filings.
$8.3MFY2025 · since FY2016: $19.6M → $8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.3M | +15.7% |
| FY2024 | $7.1M | -20.8% |
| FY2023 | $9.0M | -33.2% |
| FY2022 | $13.5M | -18.9% |
| FY2021 | $16.6M | +26.8% |
| FY2020 | $13.1M | +0.9% |
| FY2019 | $13.0M | -14.4% |
| FY2018 | $15.2M | -10.1% |
| FY2017 | $16.9M | -13.9% |
| FY2016 | $19.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPHI financial trends
CPHI RevenueCPHI Net incomeCPHI Net marginCPHI Gross profitCPHI Gross marginCPHI Operating incomeCPHI Operating marginCPHI Operating cash flowCPHI Free cash flowCPHI Capital expendituresCPHI Return on equityCPHI Stock buybacksCPHI Dividends paidCPHI Total assetsCPHI Shareholders’ equityCPHI overview →